Physician Wealth Advisors’s Novavax NVAX Stock Holding History

Physician Wealth Advisors’s Portfolio NVAX Stock Details NVAX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$462	Buy	49 +45	+1,125%	+$403	﹤0.01%	2170
2026 Q1	$33	Hold	4	–	–	﹤0.01%	2048
2025 Q4	$27	Sell	4 -99	-96%	-$746	﹤0.01%	2019
2025 Q3	$894	Hold	103	–	–	﹤0.01%	1643
2025 Q2	$649	Buy	103 +99	+2,475%	+$656	﹤0.01%	1636
2025 Q1	$26	Hold	4	–	–	﹤0.01%	1426
2024 Q4	$33	Buy	+4	New	+$39	﹤0.01%	1137

Other funds holding NVAX

Sanofi Paris, France $534M AUM 205.96% 1-Year Est. Return

TCMG

TSP Capital Management Group Summit, New Jersey $418M AUM 68.45% 1-Year Est. Return

OAM

OP Asset Management Helsinki $9.38B AUM 42.35% 1-Year Est. Return

STRS Ohio Columbus, Ohio $26.7B AUM 43.32% 1-Year Est. Return

Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return

ALPS Advisors Denver, Colorado $21.3B AUM 23.41% 1-Year Est. Return

PAG

Private Advisor Group Morristown, New Jersey $21.8B AUM 28.57% 1-Year Est. Return

PFSRSONJ

Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return

New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return

YIH

Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return

Physician Wealth Advisors's NVAX Position: Q2 2026 in Review

Physician Wealth Advisors increased its Novavax (NVAX) stake by 1,125% in Q2 2026, buying an estimated $403 and bringing the position to 49 shares worth $462. The position accounts for ﹤0.01% of the portfolio, ranked #2170.

Physician Wealth Advisors first reported a position in NVAX in Q4 2024 and has held it in 7 quarters since. The position peaked at $894 in Q3 2025. 64 funds tracked by Wall St. Rank hold NVAX as of Q2 2026.

Physician Wealth Advisors held 49 shares of Novavax worth $462 as of Q2 2026.
Physician Wealth Advisors bought 45 Novavax shares in Q2 2026, an estimated $403.
Novavax made up ﹤0.01% of Physician Wealth Advisors's portfolio in Q2 2026, its #2170 holding.
Physician Wealth Advisors first reported a position in Novavax in Q4 2024 and has held it in 7 quarters since.
Physician Wealth Advisors's Novavax position peaked at $894 in Q3 2025.
64 funds tracked by Wall St. Rank held Novavax as of Q2 2026.

Based on Physician Wealth Advisors's 13F filing for Q2 2026, filed 20 Jul 2026.